Search Within

Jose T Baselga

  1. "Tzy-Jyun Yao"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (8)
  2. Behavioral Sciences Service (8)
  3. Breast Medicine Service (8)
  4. Department of Medicine (8)
  5. Psychiatry and Behavioral Sciences, Department of (8)
  6. Solid Tumor Oncology Division (8)

More Groups

People
  1. Tzy-Jyun Yao (9)
  2. Andrew Seidman (8)
  3. Clifford Hudis (8)
  4. Larry Norton (8)
  5. Teresa Gilewski (8)
  6. David Fennelly (6)

More People

Years
  1. 1999 (2)
  2. 1998 (1)
  3. 1996 (2)
  4. 1995 (3)
  5. 1993 (1)
Publications
  1. Journal of Clinical Oncology (4)
  2. Breast Cancer Research and Treatment (1)
  3. Cancer Investigation (1)
  4. Clinical Cancer Research (1)
  5. Oncogene (1)
  6. Seminars in Oncology (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (1)
  3. Elsevier Inc. (1)
  4. Informa Healthcare (1)
  5. Nature Publishing Group (1)
  6. Springer (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer
    Journal Article

    D'Andrea, G.; Fennelly, D.; Norton, L.; Baselga, J.; Gilewski, T.; Hudis, C.; Moynahan, M. E.; Raptis, G.; Sklarin, N.; Surbone, A.; more...
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: Feasibility and efficacy
    Journal Article

    Hudis, C.; Seidman, A.; Baselga, J.; Raptis, G.; Lebwohl, D.; Gilewski, T.; Moynahan, M.; Sklarin, N.; Fennelly, D.; Crown, J. P. A.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • Lack of increased cardiac toxicity with sequential doxorubicin and paclitaxel
    Journal Article

    Hudis, C.; Riccio, L.; Seidman, A.; Baselga, J.; Currie, V.; Fennelly, D.; Gilewski, T.; Lebwohl, D.; Moynahan, M.; Raptis, G.; more...
    Cancer Investigation (1998)

    Fulltext@MSK | Save
  • Event-free survival after sequential dose-dense doxorubicin (A), paclitaxel (T) and cyclophosphamide (C) in women (pts) with ≥ 4 positive (+) axillary lymph nodes (LN)
    Meeting Abstract

    Hudis, C.; Seidman, A.; Raptis, G.; Baselga, J.; Gilewski, T.; Fennelly, D.; Lebwohl, D.; Surbone, A.; Currie, V.; Moynahan, M.; more...
    Breast Cancer Research and Treatment (1996)

    Fulltext@MSK | Save
  • Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: A phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer
    Journal Article

    Seidman, A. D.; Hochhauser, D.; Gollub, M.; Edelman, B.; Yao, T. J.; Hudis, C. A.; Francis, P.; Fennelly, D.; Gilewski, T. A.; Moynahan, M. E.; more...
    Journal of Clinical Oncology (1996)

    Fulltext@MSK | Save
  • Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes
    Journal Article

    Hudis, C. A.; Seidman, A. D.; Baselga, J.; Raptis, G.; Lebwohl, D.; Gilewski, T.; Currie, V.; Moynahan, M. E.; Sklarin, N.; Fennelly, D.; more...
    Seminars in Oncology (1995)

    Fulltext@MSK | Save
  • Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer
    Journal Article

    Seidman, A. D.; Tiersten, A.; Hudis, C.; Gollub, M.; Barrett, S.; Yao, T. J.; Lepore, J.; Gilewski, T.; Currie, V.; Crown, J.; more...
    Journal of Clinical Oncology (1995)

    Fulltext@MSK | Save
  • Paclitaxel as second and subsequent therapy for metastatic breast cancer: Activity independent of prior anthracycline response
    Journal Article

    Seidman, A. D.; Reichman, B. S.; Crown, J. P. A.; Yao, T. J.; Currie, V.; Hakes, T. B.; Hudis, C. A.; Gilewski, T. A.; Baselga, J.; Forsythe, P.; more...
    Journal of Clinical Oncology (1995)

    Fulltext@MSK | Save
  • Over-expression of transforming growth factor α antagonizes the anti-tumorigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cell
    Journal Article

    Baselga, J.; Maerz, W. J.; Moy, D.; Miller, W. H. Jr; Castro, L.; Reuter, V. E.; Yao, T. J.; Masui, H.; Dmitrovsky, E.
    Oncogene (1993)

    Fulltext@MSK | Save